Molecular Targeted Radionuclide Therapy for Prostate Cancer

Main Article Content

Saima Muzahir, MD
Erin E. Grady, MD
Scott J. Lee, MD

ABSTRACT


According to the American Cancer Society, prostate cancer affects 1 in 8 men. This chapter reviews the molecular targeted radionuclide therapy for prostate cancer, including pretherapy imaging and evaluation, considerations during the course of therapy, and follow-up. Dosimetry and alpha-particle therapies are also discussed.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

Section
Chapter 10